Senior Director, Disease Biology

Arc Institute

Where
Palo Alto, CA
Pay
$264K to $326K a year

Posted 2 months ago· Checked live at Arc Institute 52 minutes ago

Stale: open 87 daysUp for more than two weeks. It may already be filled.

See how you score for this job

One sentence and your resume. We score it against what Arc Institute asks for, line by line.

See my score
Is this job still open?
Yes. We checked it live on Arc Institute's own hiring page 52 minutes ago.
What is the job?
Arc Institute is an independent nonprofit research organization at the interface of artificial intelligence and biology, working to accelerate scientific progress and understand the root causes of complex diseases. Founded in 2021 and based in Palo Alto, Arc partners with Stanford University, UC Berkeley, and UC San Francisco. Unlike academia, our scientists have long-term funding and industry-like resources.
What does it pay?
$264K to $326K a year, as the posting states.
Our verdict
Stale. Up for more than two weeks. It may already be filled.

What the job is

Arc Institute is an independent nonprofit research organization at the interface of artificial intelligence and biology, working to accelerate scientific progress and understand the root causes of complex diseases. Founded in 2021 and based in Palo Alto, Arc partners with Stanford University, UC Berkeley, and UC San Francisco.

Unlike academia, our scientists have long-term funding and industry-like resources.

About you

We are looking for a driven, resilient leader who is passionate about advancing how we understand disease and fearless in pursuing therapeutic opportunities that change patients' lives. Someone who builds, grows, and mentors strong teams, sets clear direction, and brings creativity and rigor to complex, ambiguous problems to accelerate discovery into the clinic.

In this position you will

  • Build a new team to carry validated targets through drug discovery into preclinical programs.
  • Guide those programs through to lead optimization, partnering with chemistry and ADI model teams to prioritize candidates and generate in vitro and in vivo proof of concept data.
  • Lead target discovery for the Initiative, translating genetic, functional genomics, and disease mapping findings into biologically grounded therapeutic targets.
  • Lead Arc's existing in vivo and in vitro ADI discovery teams, shaping their work to sharpen target identification and validation.
  • Partner with computational biology and machine learning teams to surface new pathway insight, apply causal modeling to test target hypotheses, and draw on patient genetics and sample databases to validate and prioritize candidates.
  • Align priorities across the target discovery and preclinical teams so concurrent programs move in a coordinated way.
  • Collaborate across the Arc community to coordinate experimental approaches and analysis, and to deepen our collective understanding of Alzheimer's disease biology.
  • Manage CRO and external partner relationships, with support from Program Management, to advance AD model generation and preclinical studies.
  • Represent discovery and preclinical strategy in cross functional target review and portfolio prioritization discussions.

Requirements

  • PhD in neuroscience, immunology, cell biology, genetics, pharmacology, or a related field.
  • Extensive experience leading target discovery in neurodegeneration, from disease biology and human genetics through target validation.
  • Track record advancing programs from validated target through lead optimization, in vivo proof of concept, and IND enabling studies, including building or partnering with the supporting toxicology and pharmacokinetics capabilities.
  • Deep expertise developing or applying advanced 3D cellular models of neurodegenerative disease.
  • Proven people leadership, including mentoring established scientific teams, building new teams and capabilities from the ground up, and running matrixed, cross functional programs.
  • Strong partnership with computational biology and machine learning teams, applying causal modeling and human genetic data to target discovery and validation.
  • Experience in a fast paced biotech or nonprofit research institute environment.
  • Ability to work onsite in our Palo Alto office a minimum of four days per week.

Preferred Qualifications

  • Direct experience in Alzheimer's disease drug discovery.
  • Hands-on experience generating and validating animal models of Alzheimer’s disease, including genetic risk variant models such as APOE4 and TREM2.
  • Experience integrating computational and machine learning driven target prioritization into discovery strategy.
  • Experience partnering with high throughput biology teams.

The base salary range for this position is $263,500 to $325,500. These amounts reflect the range of base salary that the Institute reasonably would expect to pay a new hire or internal candidate for this position. The actual base compensation paid to any individual for this position may vary depending on factors such as experience, market conditions, education/training, skill level, and whether the compensation is internally equitable, and does not include bonuses, commissions, differential pay, other forms of compensation, or benefits. This position is also eligible to receive an annual discretionary bonus, with the amount dependent on individual and institute performance factors.

In addition to the Base Salary and Annual Bonus above, you will be eligible to participate in the Institute’s Compound Cash Grant Program (the “CCGP”). The CCGP is a program designed to offer multi-year cash grants providing for a fixed dollar amount paid out in semi-annual installments to reward employees for staying and contributing to the Institute. As soon as reasonably practical after your start date, you will receive a grant letter describing the terms of your award under the CCGP.

Similar open jobs

Jobs in San Jose (7810)